Regulatory and Competitive Barriers in Earwax Removal for Consumer Health Brands

The earwax removal market is a growing segment within consumer health, driven by increasing awareness of ear hygiene and the demand for safe, effective, and convenient solutions. However, brands looking to enter or expand in this space face a complex landscape of regulatory and competitive barriers. 

This blog explores the compliance challenges, regulatory distinctions between over-the-counter (OTC) and prescription earwax removal treatments, and the strategies brands can use to compete successfully.

Earwax Removal Regulations: Compliance Challenges

One of the most challenging issues for companies entering the earwax removal space is the lack of harmonisation across regulatory frameworks. While some countries classify earwax removal products as OTC drugs, others treat them as solution-based medical devices, each with its own dossier requirements and clinical validation standards.

For instance, in the European Union, any device that claims to diagnose, prevent, monitor, or treat a medical condition (including earwax blockage) must comply with the Medical Device Regulation (MDR). This means manufacturers must demonstrate safety and performance through clinical evaluation, technical documentation, and, for higher-risk devices, conformity assessment. Outside Europe, in markets like Brazil, similar technical files may result in completely different classifications (from medical OTC products), depending on local interpretation.

This lack of regulatory consistency can delay market entry, increase compliance costs, and raise barriers for companies without local regulatory partners.

OTC vs. Prescription Earwax Removal Treatments: Regulatory and Market Implications

The regulatory pathway for earwax removal treatments differs significantly depending on whether the product is available OTC or by prescription. A common question among brands is: Who can safely remove earwax? The answer depends on local regulations. 

In many European countries, earwax removal specialists, such as audiologists or ear, nose, and throat (ENT) professionals, are authorised to perform these procedures. For consumer products, earwax removal certification or license may not be required for OTC sales, but the product itself must be certified as compliant with relevant regulations. This distinction is crucial for brands to understand when developing their go-to-market strategy.

• OTC earwax removal products

OTC products, such as earwax removal drops, sprays, and irrigation kits, are generally classified as low-risk medical devices or consumer health products. Whatever the case may be, they must still comply with efficacy, safety and labelling requirements.

• Professional treatments

Professional earwax removal treatments, such as those performed by earwax removal specialists, are subjected to more stringent regulations. The healthcare professionals (nurses, doctors and audiologists) who carry them out require specific training.

OTC brands can reach a broader consumer base but must invest in education and trust-building while professional practices can leverage insurance coverage and professional endorsements but face higher regulatory and market entry barriers.

Competing in a Regulated Market: Strategies for Consumer Health Brands

Once compliance has been achieved, brands must face trade barriers: how to enter and succeed in markets where competition is already strong. Usually, the local leaders in earwax removal treatments have the confidence of pharmacists, extensive retail coverage, and strong brand recognition. Challenging it requires a strategic approach.

• Differentiate through innovation

Brands can stand out by offering innovative and differentiating products. For example, OTC earwax removal products that combine safety, efficacy, and user-friendly design can appeal to both consumers and healthcare professionals. Highlighting features such as a gentle formulation can also create a competitive edge.

• Invest in education and awareness

Many consumers are unaware of the risks associated with improper earwax removal or the benefits of using certified products. Brands that invest in educational campaigns, targeting both consumers and healthcare professionals, can build trust and establish themselves as authorities in the market.

• Invest in healthcare professional engagement

Collaborating with otology key opinion leaders and obtaining support from professional ENT entities and associations can enhance credibility and facilitate market entry. In consolidated markets, forming partnerships with clinics and insurance providers can also help brands establish themselves.

• Ensure regulatory compliance and adaptability

Given the complexity of regulations for these types of products, brands must prioritise compliance from the outset. This includes obtaining the necessary certification or device approvals, ensuring accurate labelling, maintaining robust post-market surveillance and adapting to the evolving regulations. Working with regulatory consultants or legal experts can help navigate the nuances of each market.

• Explore the insurance and reimbursement opportunities 

Due to OTC products are rarely covered by earwax removal insurance, brands can search for partnerships with insurance providers for professional or prescription products. This can be a key differentiator in markets where insurance coverage influences consumer choice.

The earwax removal market presents both opportunities and challenges for consumer health brands. Regulatory compliance, market access, and competitive differentiation are critical factors for success, especially in consolidated markets. By understanding the nuances of earwax removal regulation, differentiating through innovation, and building strong relationships with professionals and insurers, brands can overcome barriers and establish a strong presence in this growing segment.

At Mitelos, besides developing, registering, and supplying ready-to-market OTC ear health products, we help companies navigate these challenges with proven regulatory expertise and market-tested ear care solutions. 

If you’re looking to bring innovative earwax removal products to regulated markets, let’s connect.

References

European Parliament and Council of the European Union. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices. Official Journal of the European Union [Internet]. 2017 May 5 [cited 2025 May 22];L117:1–175. Available from: https://eur-lex.europa.eu/eli/reg/2017/745/oj/eng